Opportunity

SAM #W912CG27SSA005

Development, testing, and prototype production of phage hygiene sprays

Buyer

Army Contracting Command - Orlando

Posted

November 20, 2026

Respond By

November 30, 2026

Identifier

W912CG27SSA005

NAICS

541714

The U.S. Army is seeking small-business capabilities for research and development of prototype phage hygiene sprays targeting UTI-causing E. coli. - Buyer: U.S. Department of the Army, through Army Materiel Command (AMC), Army Contracting Command (ACC), ACC-APG, and W6QK ACC-APG-Orlando. - Opportunity: Sources-sought notice for a potential R&D effort; no solicitation or award is being made through this notice. - OEMs and vendors: No OEMs, vendors, or commercial brands are named. The Army will provide the phage cocktail. - Requested products: 100 prototype spray bottles total: 50 with phage cocktail and 50 with optimized formulation only. No part numbers are specified. - Each bottle must be an opaque 15 ml HDPE container holding 14 ml, with a 70–150 μl fine-mist pump, 360-degree spray capability, and a heat-shrunk seal. Bottles require numbered labels, separate protective packaging, and overnight delivery on ice or ice packs. - Requested services: Develop three formulation iterations; optimize the formulation; conduct freeze/thaw, accelerated heat-stability, preservative challenge, and Human Repeated Insult Patch Test (HRIPT) testing; assess ingredient toxicity; and support applicable Modernization of Cosmetic Regulation Act (MoCRA) requirements. - Notable technical requirements: The phage formulation must exceed 1E8 PFU/ml, use a pH 7–7.5 buffer, and maintain activity during storage at 45°C for four weeks. Formulations may include stabilizers, preservatives or enhancers, and moisturizers. - Requested capabilities: Respondents should demonstrate experience with phage and cosmetic formulation, prototype development, and thermal-stability testing.

Description

This is a Small Business Sources Sought notice. This is NOT a solicitation for quote. The purpose of this notice is to obtain information regarding the availability and capability of all qualified small business sources to perform a potential R&D requirement.

This notice is issued to help determine the availability of qualified small business sources technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only.

Background: This project seeks to design and test spray suitable for phage hygiene products formulation for the prevention of UTI that maintain activity under extreme thermal conditions. Once a spray formula is identified and passes all necessary testing, prototype spray devices will be assembled for testing. The requesting organization has identified a phage cocktail having suitable activity and stability in lab-based solutions. The requesting organization has test potential formulation components used for topical skin applications for maintenance of titer and stability. Various components include phage storage buffer solutions, preservatives, potentiators, emollients, humectants and other additives utilized cosmetic products.

“In accordance with FAR 37.104(a), this requirement does not constitute a personal services contract as it does not create an employer-employee relationship. All tasks will be executed independently by the contractor, and the Government will not exercise direct supervision or control over contractor personnel.”.

Purpose/Objective: This request is to conduct the development, safety testing, and production of custom prototype bacteriophage hygiene sprays designed for intimate skin applications to target UTI-causing E. coli. The Contractor shall design, develop and test a phage friendly formulation for prototype cosmetic phage hygiene sprays. Phage formulation properties will include maintenance of thermal stability and possess suitable properties for manufacture of prototype cosmetic products. Components must not inhibit or otherwise reduce phage titer during storage, including at elevated temperature (45oC) for 4 weeks.

Project Requirements: Standard topical cosmetic manufacturers lack the biological expertise to handle live phages, while traditional phage laboratories do not possess the cosmetic-adjacent formulation infrastructure for sensitive skin areas. Contractors are sought that should have previous experience working with phage for cosmetic products, including making prototypes and formulation development for thermal stability needed for product storage at elevated temperatures that meet cosmetic regulatory requirements. The Contractor shall provide project management support for the overall administration of the contract and development, tracking, and management of all task orders issued under the contract. The Contractor’s support staff shall work in coordination with designated federal staff and be responsible for performing all the non-inherently governmental activities associated with administration of this contract.

Task Area 1: Formula development & optimization The contractor shall independently formulate and deliver three (3) formulation iterations incorporating provided phage cocktail. The contractor shall independently analyze this data to determine and execute subsequent formulation adjustments, leveraging its proprietary prototyping expertise to deliver the next physical iteration. Following the delivery of each iteration prototype, the requesting organization will provide data of the formulation effect on Phage thermal stability/titer and determination of formulation suitability for potential inclusion into prototype sprays. Iteration 1 will be formulated by the contractor using previous data generated by the requesting organization and will be sent to requestor for evaluations/assessment. The requestor will return the results of Phage cocktail thermal stability/titer thermal stability data to contractor. Iteration 2 will be developed after the contractor receives the assessment results for iteration 1. The contractor will assess the results to inform adjustments/changes to the spray formulation composition to improve/maintain phage cocktail thermal stability/titer at 45oC storage. This may involve adjusting formulation concentrations or substituting alternatives components within the limitations described by the requestor. This iteration will be sent to the requestor for evaluations/assessment of Phage cocktail thermal stability/titer. Iteration 3 will be developed by the contractor after receiving the results of the iteration 2 evaluations. The contractor will assess the results to inform adjustments/changes to the spray formulation composition to maintain/improve phage cocktail thermal stability/titer at 45oC storage. This may involve adjusting formulation concentrations or substituting alternatives components within the limitations described by the requestor. This iteration will be sent to the requestor for evaluation/of stability properties as the final formulation. Formulation Testing: Formulation components will be combined and assessed for: 1) thermal stability (3-cycle freeze/thaw testing and accelerated heat stability testing); 2) preservative challenge test; and 3) Human Repeated Insult Path Test (HRIPT).

Task Area 2: Prototype production – Once formulation is finalized, prototype spray bottles will be made containing phage cocktail in optimized formulation, and formulation only (no phage): Optimized formulation that maintains thermal stability and suitable for prototype cosmetic sprays. Components include phage cocktail (concentration >1E8 PFU/ml), phage buffer (pH 7 to 7.5), stabilizer(s), preservative(s)/enhancer, moisturizer(s) (humectants/emollients). Number of units: 50 bottles with phage cocktail in optimized formulation, 50 bottles containing formulation only. Prototypes delivered to requestor overnight on ice or ice packs. Spray bottle volume: 15 ml (0.5 oz), with 14 ml solution. Spray bottles must have fine mist pump delivery (70–150 ul). Spray bottles must have 360-degree delivery (including when sprayed upside down). Spray bottle material: opaque plastic (HDPE). Spray bottle caps and neck to be sealed with heat-shrunk plastic. Spray bottles to be labeled numerically 1 to 50 (for formulation only, no phage) and 51 to 100 (for phage cocktail in optimized formulation). Package spray bottles numbered 1-50 separately from bottles numbered 51-100. Use cardboard boxes with dividers to keep the bottles protected and separated. The contractor will purchase suitable spray bottles.

Regulatory process: Establish that the product meets Modernization of Cosmetic Regulation Act Compliance (MoCRA) specifications: Preservative Challenge Testing: ensures the product remains free from bacterial, yeast and mold contamination during storage. Ingredients Toxicity Study: A safety assessment to determine the toxicity of individual ingredients in the formula based on published studies and safety assessments in cosmetic products.

The prototypes from this procurement will be evaluated in a user acceptability study by female Warfighters.

Capability statement/information sought. Respondents must provide clear and convincing documentation of their capability of providing the manufacturing and studies support services specified in this notice.

Respondents must also provide their DUNS number, organization name, address, point of contact, and size and type of business (e.g., 8(a), HubZone, etc., pursuant to the applicable NAICS code and any other information that may be helpful in developing or finalizing the acquisition requirements.

Respondents must submit their response in Microsoft Word or Adobe PDF format using 11-point or 12-point font, 8-1/2” x 11” paper size, with 1” top, bottom, left and right margins, and with single or double spacing.

The information submitted must be in an outline format that addresses each of the elements of the project requirement and in the capability statement/information sought paragraphs stated herein. A cover page and/or an executive summary may be included but are not required.

Responses are limited to ten (10) pages. The 10-page limit does not include the cover page, executive summary, or references, if requested.

Responses must include the respondents’ technical and administrative points of contact, including names, titles, addresses, telephone and fax numbers, and e-mail addresses.

All responses must be submitted to Justin Woolsey, Contract Specialist, via e-mail: justin.h.woolsey.civ@army.mil. Facsimile responses are NOT accepted.

Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work.

Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published in SAM. However, responses to this notice will not be considered adequate responses to a solicitation.

Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

View original listing